AG真人官方

STOCK TITAN

[SCHEDULE 13D/A] Indivior PLC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 搂搂 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Two Seas Capital LP
Signature:/s/ Sina Toussi
Name/Title:Sina Toussi/Managing Member of Two Seas Capital GP LLC, its general partner
Date:07/29/2025
Two Seas Capital GP LLC
Signature:/s/ Sina Toussi
Name/Title:Sina Toussi/Managing Member
Date:07/29/2025
Sina Toussi
Signature:/s/ Sina Toussi
Name/Title:Sina Toussi/Self
Date:07/29/2025
Indivior

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

2.92B
119.93M
3.88%
94.35%
5.71%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
SLOUGH, BERKSHIRE